B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease
- PMID: 14755370
- DOI: 10.1002/ajh.10442
B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease
Abstract
Red blood cells from patients with sickle cell disease (SS RBC) adhere to laminin and over-express the high-affinity laminin receptor basal cell adhesion molecule/Lutheran protein (B-CAM/LU). This receptor has recently been shown to undergo activation in vitro through a protein kinase A-dependent mechanism. Low-density SS RBC express two-thirds more B-CAM/LU than high-density SS RBC. However, high-density SS RBC have been identified as most adherent to laminin under flow conditions. We investigated the ability of low- and high-density SS RBC to interact with laminin under various conditions and explored factors that might be responsible for the differences in B-CAM/LU-laminin interaction between high- and low-density SS RBC. We confirmed that high-density SS RBC adhere to laminin more strongly than low-density SS RBC under flow conditions. However, low-density SS RBC bind soluble laminin most strongly and are the most adherent to laminin under static conditions. Soluble recombinant Lutheran extracellular domain protein completely blocked SS RBC adhesion to laminin under both static and flow conditions. The protein kinase A inhibitor 14-22 amide inhibited adhesion to laminin during flow by high-density SS RBC from patients with strongly adherent cells but had no effect on adhesion observed after a static phase. Deletion of the cytoplasmic domain of B-CAM as well as mutation of the juxtamembranous tyrosine residue failed to reduce B-CAM-mediated adhesion to laminin by transfected MEL cells. These studies confirm that B-CAM/LU is the most critical receptor mediating adhesion to laminin under both static and flow conditions. Dense SS RBC are most adherent to laminin despite bearing fewer laminin receptors, apparently due to a reversible protein kinase A-dependent process that is unlikely to involve direct phosphorylation of B-CAM/LU. Our results also suggest that the nature of the interaction of B-CAM/LU with laminin may be different under static and flow conditions.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
-
Role of Lu/BCAM in abnormal adhesion of sickle red blood cells to vascular endothelium.Transfus Clin Biol. 2008 Feb-Mar;15(1-2):29-33. doi: 10.1016/j.tracli.2008.05.002. Epub 2008 Jun 2. Transfus Clin Biol. 2008. PMID: 18514010
-
Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues.Connect Tissue Res. 2005;46(4-5):193-9. doi: 10.1080/03008200500344074. Connect Tissue Res. 2005. PMID: 16546822 Review.
-
Role of the interaction between Lu/BCAM and the spectrin-based membrane skeleton in the increased adhesion of hereditary spherocytosis red cells to laminin.Br J Haematol. 2010 Feb;148(3):456-65. doi: 10.1111/j.1365-2141.2009.07973.x. Br J Haematol. 2010. PMID: 20092464
-
The Lutheran glycoprotein: a multifunctional adhesion receptor.Transfusion. 2006 Apr;46(4):668-77. doi: 10.1111/j.1537-2995.2006.00779.x. Transfusion. 2006. PMID: 16584446 Review.
-
Role of Lu/BCAM glycoproteins in red cell diseases.Transfus Clin Biol. 2010 Sep;17(3):143-7. doi: 10.1016/j.tracli.2010.06.002. Epub 2010 Jul 23. Transfus Clin Biol. 2010. PMID: 20655789
Cited by
-
The Gardos effect drives erythrocyte senescence and leads to Lu/BCAM and CD44 adhesion molecule activation.Blood Adv. 2020 Dec 22;4(24):6218-6229. doi: 10.1182/bloodadvances.2020003077. Blood Adv. 2020. PMID: 33351118 Free PMC article.
-
Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging.Blood Adv. 2018 Jan 3;2(1):14-24. doi: 10.1182/bloodadvances.2017013094. eCollection 2018 Jan 9. Blood Adv. 2018. PMID: 29344581 Free PMC article.
-
Effect of propranolol as antiadhesive therapy in sickle cell disease.Clin Transl Sci. 2012 Dec;5(6):437-44. doi: 10.1111/cts.12005. Epub 2012 Oct 17. Clin Transl Sci. 2012. PMID: 23253664 Free PMC article. Clinical Trial.
-
The genomic analysis of erythrocyte microRNA expression in sickle cell diseases.PLoS One. 2008 Jun 4;3(6):e2360. doi: 10.1371/journal.pone.0002360. PLoS One. 2008. PMID: 18523662 Free PMC article.
-
Catch bonds in sickle cell disease: Shear-enhanced adhesion of red blood cells to laminin.Biophys J. 2023 Jun 20;122(12):2564-2576. doi: 10.1016/j.bpj.2023.05.010. Epub 2023 May 12. Biophys J. 2023. PMID: 37177783 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous